| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 19,000 | 19,800 | 08:02 | |
| 19,154 | 19,736 | 08:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | MiniMed Group, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| MINIMED GROUP Aktie jetzt für 0€ handeln | |||||
| 04.09. | Why MiniMed Stock Was Soaring This Week | 7 | The Motley Fool | ||
| 04.09. | MiniMed: Q1 Fiscal 2027 Revenue Rises 17% To $843 Million And Guidance Is Raised | 7 | pulse2.com | ||
| 02.09. | Analysten-Upgrades treiben Aktie der MiniMed Group an | 25 | Investing.com Deutsch | ||
| 02.09. | StoneX raises MiniMed Group stock price target to $27 on results | 7 | Investing.com | ||
| 02.09. | These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results | 7 | Benzinga.com | ||
| 02.09. | UBS raises MiniMed Group stock price target to $28 on strong quarter | 7 | Investing.com | ||
| 02.09. | BofA raises MiniMed stock price target to $28 on FDA submission | 7 | Investing.com | ||
| 02.09. | Wells Fargo raises MiniMed Group stock price target to $26 on sales beat | 10 | Investing.com | ||
| 02.09. | Biotech Stocks At 52-Week Highs - MiniMed Group +10%, Pulse Biosciences, Solventum, Royalty Pharma, Apogee Therapeutics | 887 | AFX News | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 1, 2026, as various companies reported financial results and reached certain regulatory milestones.MiniMed... ► Artikel lesen | |
| 01.09. | BTIG raises MiniMed Group stock price target on pipeline progress | 7 | Investing.com | ||
| 01.09. | MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance | 6 | MassDevice | ||
| 01.09. | MiniMed projects ~10.5% fiscal 2027 organic revenue growth as Flex expands and Fit targets U.S. launch by summer 2027 | 11 | Seeking Alpha | ||
| 01.09. | Warum die MiniMed Aktie heute stark zulegt | 9 | Investing.com Deutsch | ||
| 01.09. | Minimed Group Q1 2027 Earnings Call Transcript | 7 | Benzinga.com | ||
| 01.09. | MiniMed Q1 FY27 slides: revenue surges 16%, guidance raised | 7 | Investing.com | ||
| 01.09. | Yext Posts Upbeat Q2 Earnings, Joins Fervo Energy, MiniMed Group And Other Big Stocks Moving Higher On Tuesday | 9 | Benzinga.com | ||
| 01.09. | StoneX reiterates Buy on MiniMed stock ahead of earnings | 7 | Investing.com | ||
| 01.09. | MiniMed Group reports mixed Q1 results; raises FY2026 outlook | 8 | Seeking Alpha | ||
| 01.09. | MiniMed Group, Inc. - 8-K, Current Report | 8 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| MEDLINE | 28,000 | 0,00 % | Jim Cramer Names Medline (MDLN) a Sleeper Compounder | ||
| OMADA HEALTH | 18,200 | 0,00 % | Omada Health, Inc.: Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day | ||
| ADVANCED BIOMED | 7,980 | -2,56 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CUPRINA HOLDINGS | 3,150 | -0,94 % | Cuprina Holdings LTD - F-1/A, Registration statement for certain foreign private issuers | ||
| CARLSMED | 12,600 | 0,00 % | Carlsmed, Inc. Announces Chief Operating Officer Appointment | CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions... ► Artikel lesen | |
| SHOULDER INNOVATIONS | 16,200 | 0,00 % | Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch | Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients
GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc.... ► Artikel lesen | |
| PARK DENTAL PARTNERS | 18,400 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| TENON MEDICAL | 5,850 | -1,35 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| FRESENIUS | 45,040 | +0,75 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
08.09.2026 / 11:02... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,440 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | -0,06 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen |